WallStreetZenWallStreetZen

NASDAQ: RNLX
Renalytix PLC Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

RNLX past revenue growth

How has RNLX's revenue growth performed historically?
Company
-36.65%
Industry
12.13%
Market
17.61%
RNLX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
RNLX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance

RNLX earnings and revenue history

Current Revenue
$2.4M
Current Earnings
-$41.8M
Current Profit Margin
-1,736.5%

RNLX Return on Equity

Current Company
-1,071.9%
Current Industry
-0.2%
Current Market
188%
RNLX's Return on Equity (-1,071.9%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when RNLX announces earnings.

RNLX Return on Assets

Current Company
-165.3%
Current Industry
0.8%
RNLX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

RNLX Return on Capital Employed

Current Company
1,581.33%
Current Industry
2.2%
RNLX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

RNLX vs Health Information Service Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
RNLX$2.41M-$41.25M-$41.85M+171.28%N/A
EUDAN/AN/AN/AN/AN/A
NUTX$247.65M-$16.81M-$45.79M+182.89%N/A
BFRG$65.00k-$5.28M-$5.36M+550.00%N/A
BEAT$0.00-$14.64M-$14.64MN/AN/A
View Top Health Information Service Stocks

RNLX earnings dates

Next earnings date
Jun 11, 2024

Renalytix Earnings & Revenue FAQ

What were RNLX's earnings last quarter?

On Invalid Date, Renalytix (NASDAQ: RNLX) reported Q4 2023 earnings per share (EPS) of -$0.18, up 35.71% year over year. Total Renalytix earnings for the quarter were -$8.49 million. In the same quarter last year, Renalytix's earnings per share (EPS) was -$0.28.

If you're new to stock investing, here's how to buy Renalytix stock.

What was RNLX's earnings growth in the past year?

As of Q2 2024, Renalytix's earnings has grown year over year. Renalytix's earnings in the past year totalled -$41.85 million.

What is RNLX's earnings date?

Renalytix's earnings date is Invalid Date. Add RNLX to your watchlist to be reminded of RNLX's next earnings announcement.

What was RNLX's revenue last quarter?

On Invalid Date, Renalytix (NASDAQ: RNLX) reported Q4 2023 revenue of $709.00 thousand up 40.52% year over year. In the same quarter last year, Renalytix's revenue was $1.19 million.

What was RNLX's revenue growth in the past year?

As of Q2 2024, Renalytix's revenue has grown -36.65% year over year. This is 48.77 percentage points lower than the US Health Information Services industry revenue growth rate of 12.13%. Renalytix's revenue in the past year totalled $2.41 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.